IL6 and non-small cell lung carcinoma: Further studies on the correlation between IL‐6, D‐dimer, and anti‐PD‐1 efficacy in NSCLC patients stratified by gender revealed that D‐dimer and IL‐6 levels were significantly associated with the risk of PFS in male patients.